Genomenon

Ann Arbor, MI · Founded 2014 · Privately Held (backing)

Developer of genome interpretation software designed to improve cancer diagnosis and treatment. Genomenon is based in Ann Arbor, MI and was founded in 2014. Its last known valuation is $68 million. It has raised $36.8 million across 4 recorded rounds; the latest was a $5.5 million early-stage round in May 2024.

Last price · $/share
—
Implied valuation
$68.0M
Total raised
$36.8M
Last round
Early Stage VC
May 2024

Who backs Genomenon?

25 investors
InvestorType
Michigan RiseVenture capital
Invest Detroit VenturesVenture capital
Innovation PartnershipsVenture capital
BeringeaVenture capital
Spring Mountain CapitalGrowth equity
Invest DetroitOther
Ann Arbor SPARK—
Atain Insurance Company—
Danmar Capital—
Green Park & Golf Ventures—
+ 15 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Genomenon investors

25 investors are on record for Genomenon, including Michigan Rise, Invest Detroit Ventures, Innovation Partnerships and Beringea. By type, the record holds 4 venture capital firms and 1 growth equity firm. The early-stage round in May 2024 drew 30 investors.

Free account
More of Genomenon with a free account
  • ·The complete investor list: 25 names
  • ·Watch Genomenon: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 25 firms already write checks for companies like Genomenon. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View